Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.
about
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recoveryEvidence-based pharmacotherapy for cerebral vasospasm.Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats.Tamoxifen and estradiol improved locomotor function and increased spared tissue in rats after spinal cord injury: their antioxidant effect and role of estrogen receptor alpha.Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytesVolume regulated anion channel currents of rat hippocampal neurons and their contribution to oxygen-and-glucose deprivation induced neuronal death.Neuroprotective effects of curdione against focal cerebral ischemia reperfusion injury in ratsNG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease.An antioxidant phytotherapy to rescue neuronal oxidative stress.Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injuryEstrogen Receptor (ER)-α36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models.Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity.Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase.17beta-estradiol protects the neonatal brain from hypoxia-ischemia.Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect stormThe failure of animal models of neuroprotection in acute ischemic stroke to translate to clinical efficacy.Analytical variables affecting analysis of F2-isoprostanes and F4-neuroprostanes in human cerebrospinal fluid by gas chromatography/mass spectrometry.cAMP response element-binding protein (CREB) and nuclear factor κB mediate the tamoxifen-induced up-regulation of glutamate transporter 1 (GLT-1) in rat astrocytesEstrogen and tamoxifen protect against Mn-induced toxicity in rat cortical primary cultures of neurons and astrocytesTargeting astrocytes for stroke therapy.Stroke neuroprotection: oestrogen and insulin-like growth factor-1 interactions and the role of microglia.Tamoxifen Administration Immediately or 24 Hours after Spinal Cord Injury Improves Locomotor Recovery and Reduces Secondary Damage in Female Rats.Tamoxifen Provides Structural and Functional Rescue in Murine Models of Photoreceptor Degeneration.DCPIB, a specific inhibitor of volume regulated anion channels (VRACs), reduces infarct size in MCAo and the release of glutamate in the ischemic cortical penumbra.Trichosanthes tricuspidata modulates oxidative toxicity in brain hippocampus against pilocarpine induced status epilepticus in mice.Tamoxifen Use Correlates with Increased Risk of the First Episode of Ischemic Cerebrovascular Disease in Older Women with Breast Cancer: A Case-Control Study in Taiwan.Raloxifene and Tamoxifen Reduce PARP Activity, Cytokine and Oxidative Stress Levels in the Brain and Blood of Ovariectomized Rats.17β-estradiol and tamoxifen protect mice from manganese-induced dopaminergic neurotoxicity.Continuous tamoxifen delivery improves locomotor recovery 6h after spinal cord injury by neuronal and glial mechanisms in male rats.The effects of soy and tamoxifen on apoptosis in the hippocampus and dentate gyrus in a pentylenetetrazole-induced seizure model of ovariectomized rats.β-Caryophyllene Attenuates Focal Cerebral Ischemia-Reperfusion Injury by Nrf2/HO-1 Pathway in Rats.Assay of Calcium Transients and Synapses in Rat Hippocampal Neurons by Kinetic Image Cytometry and High-Content Analysis: An In Vitro Model System for Postchemotherapy Cognitive Impairment.
P2860
Q28072325-7B2EB653-D0A2-42AF-ADA2-93F13C7EBF3EQ33395885-3333800B-B1B8-4EAF-BAF7-65157AA9842CQ33523047-03117126-E4E2-4AE2-8146-296ECBAA2DE2Q33715453-D2D58054-631B-493F-B785-C430ED942FA1Q33769843-535EE693-730A-4444-AE36-67CD02072A51Q33828450-2AD465B4-BE46-4A1B-822B-CE46A35FBAEAQ33884367-35DC3AC9-B01D-45E7-A2AA-4388879ADA73Q34714437-40DD2FD2-4CC0-4C4A-9C06-865EF995E32EQ35116479-0D6808EA-004C-40C5-B7ED-4A1E72FF3D18Q35403338-18078E4C-0DD1-4180-9CFF-2C511F23FFBCQ35814382-C93612C7-D18C-41A0-B6C6-C7B1213DC88CQ35827422-137DD700-9BCA-4876-8EB4-C9FC1B340AE4Q36372549-12CEF34F-CD9F-4D42-A149-A1DDB1DEC40EQ36372729-F2D0BA60-AFFD-40B4-8C72-C2C3F26D1E02Q36377527-10AA4572-F2D2-44C4-9793-6BDC910D6016Q36802095-144B7C0D-03B7-4A3D-A8F7-5B28A80E83C0Q37055201-B25CBCAB-8CFA-4CE3-A5BE-19732E96FA98Q37213877-A91BF210-D601-4B1B-BF5D-86FAE3F5C444Q37227348-D717B2E1-3FBE-4779-91E0-2789993FF591Q37794392-54405404-6E7A-4270-ABF3-F70C5981AA09Q38114130-44C2A52D-9F75-423C-9FFC-69FF46525545Q41177498-BEF8F8B8-5E21-43FA-AEC9-AC00BD1FD135Q41700375-6F664E1A-8474-4BDB-9E2F-DF65F42F0D11Q41899236-C28E2838-DE6E-406E-902B-044BD07E9243Q44122594-B4CDAAF4-75BB-46A6-9DF1-F3115DB061C2Q44328480-FB0BBF84-2099-429B-8BF6-4F54AAF6FA09Q46523990-017F9CD0-FC19-4CF5-B229-5DA436EECE96Q47355274-3C29156B-E0D4-4A48-8919-62451BB8A25AQ47607904-5624CAEF-28D3-4FF3-B224-10430910FFCFQ47832392-09EFDD68-3183-4F6E-951F-21E445E6969EQ48954928-5443A1F5-D003-4914-B18A-4657D84EB15CQ50882231-69FB5369-72F8-4A00-B2D8-8A5C28DFF175
P2860
Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neuroprotection by tamoxifen i ...... ted with antioxidant activity.
@ast
Neuroprotection by tamoxifen i ...... ted with antioxidant activity.
@en
type
label
Neuroprotection by tamoxifen i ...... ted with antioxidant activity.
@ast
Neuroprotection by tamoxifen i ...... ted with antioxidant activity.
@en
prefLabel
Neuroprotection by tamoxifen i ...... ted with antioxidant activity.
@ast
Neuroprotection by tamoxifen i ...... ted with antioxidant activity.
@en
P2093
P2860
P1476
Neuroprotection by tamoxifen i ...... ted with antioxidant activity.
@en
P2093
Harold K Kimelberg
Paul J Feustel
Yonghua Zhang
P2860
P304
P356
10.1016/J.EXPNEUROL.2007.01.015
P407
P577
2007-01-24T00:00:00Z